Rckt stock forecast.

Stock Price Forecast. The 14 analysts offering 12-month price forecasts for Denali Therapeutics Inc have a median target of 44.00, with a high estimate of 105.00 and a low estimate of 26.00. The ...

Rckt stock forecast. Things To Know About Rckt stock forecast.

Nov 6, 2023 · On November 6, 2023, Rocket Pharmaceuticals Inc (RCKT) stock had an impressive performance, with analysts forecasting a significant increase in its price. According to data from CNN Money, the 11 analysts offering 12-month price forecasts for RCKT have a median target of $48.00, with a high estimate of $65.00 and a low estimate of $39.00. Rhythm Pharmaceuticals Inc. 34.64. +1.11. +3.31%. Get Rocket Pharmaceuticals Inc (RCKT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Stock Price Forecast The 12 analysts offering 12-month price forecasts for C3.ai Inc have a median target of 27.50, with a high estimate of 42.00 and a low estimate of 14.00.The current Rocket Companies [ RKT] share price is $9.01. The Score for RKT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal. RKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Stock Price Forecast. The 14 analysts offering 12-month price forecasts for Denali Therapeutics Inc have a median target of 44.00, with a high estimate of 105.00 and a low estimate of 26.00. The ...

Discover historical prices for RCKT stock on Yahoo Finance. View daily, weekly or monthly format back to when Rocket Pharmaceuticals, Inc. stock was issued.

Sep 13, 2023 · According to 5 analyst offering 12-month price targets in the last 3 months, Rocket Pharmaceuticals has an average price target of $53.8 with a high of $61.00 and a low of $47.00. Below is a ... The average one-year price target for RCKT / Rocket Pharmaceuticals Inc is $53.754. The forecasts range from a low of $39.39 to a high of $78.75. A stock’s price target is the price at which analysts consider it fairly valued with respect to …5 analysts have issued 1 year target prices for PDC Energy's stock. Their PDCE share price targets range from $74.00 to $93.00. On average, they anticipate the company's stock price to reach $80.75 in the next twelve months. This suggests a possible upside of 9.3% from the stock's current price. View analysts price targets for PDCE or …RCKT Stock 12 Months Forecast. $54.29. (137.59% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Rocket Pharmaceuticals in the last 3 months. The average price target is $54.29 with a high forecast of $65.00 and a low forecast of $39.00.

The average one-year price target for RCKT / Rocket Pharmaceuticals Inc is $53.754. The forecasts range from a low of $39.39 to a high of $78.75. A stock’s price target is the price at which analysts consider it fairly valued with respect to …

Rocket Companies Stock Forecast 11 Nov. Presumably, on 11/11/2023, the price of shares will be in the range of $7.05 - $7.30. A $0.25 range width can provide 3.61% volatility. The weighted average price of this range is at $7.16, which is $0.06 higher than the previous day's weighted average price.

It focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket Pharmaceuticals Inc., formerly known as Inotek Pharmaceuticals Corporation, is based ...Rocket Companies , the parent company of mortgage lending giant Quicken Loans, has set the terms of its initial public offering. The company announced Wednesday night that it plans to sell 100 ...A high-level overview of Rocket Pharmaceuticals, Inc. (RCKT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Find the latest PermRock Royalty Trust (PRT) stock quote, history, news and other vital information to help you with your stock trading and investing.(See RCKT stock analysis on TipRanks) ... The median home sale price will fall 1.7% next year after eking out an anticipated 0.2% gain in 2023, according to the forecast. 6h ago.RKT Earnings Date and Information. Rocket Companies last posted its quarterly earnings data on November 2nd, 2023. The reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. The company earned $1.20 billion during the quarter, compared to the consensus estimate of $1.08 billion.Stock Price Forecast. The 25 analysts offering 12-month price forecasts for Confluent Inc have a median target of 24.00, with a high estimate of 34.00 and a low estimate of 19.00. The median ...

US77313F1066. Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and …Rocket Pharmaceuticals, Inc. ( RCKT) NASDAQ · USD Watchlist 22.25 +0.34 (1.55%) At close: Nov 24, 2023, 1:00 PM 22.35 +0.10 (0.45%) After-hours: Nov 24, 2023, 4:48 PM EST Overview Financials Statistics Forecast Dividends Profile Chart 1D 5D 1M YTD 1Y 5Y Max 1.55% ( 1D) About RCKTStock Price Forecast. The 7 analysts offering 12-month price forecasts for PDS Biotechnology Corp have a median target of 18.00, with a high estimate of 25.00 and a low estimate of 14.00. The ...At last glance, Rocket Pharmaceuticals stock was up 42.6% at $21.80, and earlier surged to $22.32 -- its highest level since June. Following a consolidation at the $16 level, this bull gap has the ...On February 28, 2023, Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) stock closed at $19.21 per share. One-month return of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) was -12.64%, and its shares gained ...RCKT stock recorded 16/30 (53%) green days with 10.12% price volatility over the last 30 days. Based on our Rocket Pharmaceuticals stock forecast, it's now a bad time to buy RCKT stock because it's trading 10.64% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only.

Rocket Pharmaceuticals RCKT, a late-stage biotechnology company, has skyrocketed 40.1% in the past three months against the industry’s decline of 11.1%.

According to 5 analyst offering 12-month price targets in the last 3 months, Rocket Pharmaceuticals has an average price target of $53.8 with a high of $61.00 and a low of $47.00. Below is a ...US77313F1066. Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and …RKT Stock 12 Months Forecast. Based on 12 Wall Street analysts offering 12 month price targets for Rocket Companies in the last 3 months. The average price target is $9.35 with a high forecast of $11.00 and a low forecast of $6.00. The average price target represents a 15.43% change from the last price of $8.10.RCKT : Rocket Pharmaceuticals stock forecast by Wall Street Analysts. The average Rocket Pharmaceuticals stock forecast from last 6 month is $55.0, and this show a -8.65% decrease in average from the prior price target of the each prediction. Also, this average forecast of $55.0 represents a 5.77% increase from the past average forecast …Rocket Lab USA, Inc. (NASDAQ:RKLB) posted its quarterly earnings data on Wednesday, November, 8th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.01. The rocket manufacturer earned $67.66 million during the quarter, compared to analyst estimates of $67.56 million.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Rocket Companies Inc Class A share forecasts, stock quote and buy / sell signals below. According to present data Rocket Companies Inc Class A's RKT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).At last glance, Rocket Pharmaceuticals stock was up 42.6% at $21.80, and earlier surged to $22.32 -- its highest level since June. Following a consolidation at the $16 level, this bull gap has the ...Rocket Pharmaceuticals soars with FDA alignment on Danon Disease trial and a robust public offering, reinforcing their RCKT stock forecastStock Price Forecast The 12 analysts offering 12-month price forecasts for Rocket Companies Inc have a median target of 9.00, with a high estimate of 11.00 and a low estimate of 6.00. Dec 1, 2023 · According to the issued ratings of 12 analysts in the last year, the consensus rating for Rocket Companies stock is Reduce based on the current 2 sell ratings, 9 hold ratings and 1 buy rating for RKT. The average twelve-month price prediction for Rocket Companies is $8.98 with a high price target of $11.00 and a low price target of $6.00.

ZUO Stock 12 Months Forecast. $12.00. (46.16% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Zuora in the last 3 months. The average price target is $12.00 with a high forecast of $12.00 and a low forecast of $12.00. The average price target represents a 46.16% change from the last price of $8.21.

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Get the latest Rocket Companies Inc (RKT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Next reporting date. February 26, 2024. EPS forecast (this quarter) -$0.93. Annual revenue (last year) $108.5M. Annual profit (last year) -$326.0M. Net profit margin.Nov 22, 2023 · Rocket Pharmaceuticals (RCKT) Stock Forecast & Price Target $21.95 +0.60 (+2.81%) (As of 11/17/2023 ET) Compare Today's Range $21.33 $22.23 50-Day Range $15.29 $24.05 52-Week Range $14.89 $24.65 Volume 744,911 shs Average Volume 909,700 shs Market Capitalization $1.98 billion P/E Ratio N/A Dividend Yield N/A Price Target $50.38 Get the latest Rocket Pharmaceuticals Inc Stock Analysis, Price Target, Stock Forecast, and, Analyst Predictions at StockTargetAdvisor! About Us Pricing Login Sign up Get Premium. Login ... This means that RCKT's stock price may go up by +138.61% over the next 12 months.The average one-year price target for RCKT / Rocket Pharmaceuticals Inc is $53.754. The forecasts range from a low of $39.39 to a high of $78.75. A stock’s price target is the price at which analysts consider it fairly valued with respect to …Rocket Pharmaceuticals Inc Follow Share $23.33 After Hours: $23.37 (0.17%) +0.040 Closed: Nov 30, 5:34:43 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Crinetics Pharmaceuticals Inc $31.79...7 Wall Street analysts have issued 12-month target prices for Rolls-Royce Holdings plc's stock. Their RR share price targets range from GBX 70 to GBX 310. On average, they predict the company's share price to reach GBX 178.50 in the next year. This suggests that the stock has a possible downside of 32.2%.Forecast . Price target. 51.82 0.00 0.00%. The 11 analysts offering 1 year price forecasts for RCKT have a max estimate of — and a min estimate of —. Analyst rating. Based on 13 analysts giving stock ratings to RCKT in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreStock Price Forecast. The 25 analysts offering 12-month price forecasts for Confluent Inc have a median target of 24.00, with a high estimate of 34.00 and a low estimate of 19.00. The median ...

View Rocket Pharmaceuticals, Inc RCKT investment & stock information. Get the latest Rocket Pharmaceuticals, Inc RCKT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Stock Price Forecast. According to 9 stock analysts, the average 12-month stock price forecast for RCKT stock stock is $48.67, which predicts an …Future criteria checks 2/6. Rocket Pharmaceuticals is forecast to grow earnings and revenue by 56.9% and 72.5% per annum respectively. EPS is expected to grow by 57.5% per annum. Return on equity is forecast to be -77.1% in 3 years.Instagram:https://instagram. best unusual options activity scannerthe best online banking appbny stockwebull how to claim free stock Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Real time Rocket Pharmaceuticals (RCKT) stock price quote, stock graph, news & analysis. profit options calculatorwhat is the best ambetter plan View the latest Reckitt Benckiser Group PLC (RKT) stock price, news, historical charts, analyst ratings and financial information from WSJ. star bulk dividend Insiders have sold a total of 30,876 shares of company stock worth $677,083 in the last quarter. 31.10% of the stock is owned by company insiders. Wall Street Analysts Forecast GrowthRCKT stock recorded 16/30 (53%) green days with 10.12% price volatility over the last 30 days. Based on our Rocket Pharmaceuticals stock forecast, it's now a bad time to buy RCKT stock because it's trading 10.64% above our forecast. Disclaimer: This is not investment advice. The information provided is for general information purposes only. Find the latest BRC Inc. (BRCC) stock quote, history, news and other vital information to help you with your stock trading and investing.